Toggle navigation
Home
Search
Services
Blog
Contact
About
Preventing Retinal Neovascularization with Nrts
Narducy, Kenneth W.
Centaur Pharmaceuticals, Inc., Sunnyvale, CA, United States
Search 16 grants from Kenneth Narducy
Search grants from Centaur Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Poxvirus-mediated change to proteasomal peptide signatures in macrophages
Spatial and Temporal Dynamics of vWF Gene Expression
ATSDRs Partnership to Promote Localized Efforts To Reduce Environmental Exposure
Isolation of Human Variant Histone Genes
WORKSHOP: ABRF2012 Satellite Educational Workshops to be held March 16-17th, 2012 in Orlando, FL
Recently added grants:
The Role of Lung Resident Mesenchymal Stem Cells in Post-Chemotherapy Lung Metastases of Breast Cancer
Dissecting EGFR Inhibitor Resistance in Glioblastoma through genome-wide CRISPR screening
Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunity
Ex vivo analysis of human brain tumor cells in a microvascular niche model
Long-term Effects of IDU, HIV, HCV and the Impact of HCV Cure on Immune Activation and Liver Fibrosis in Aging Women
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43EY011061-01A1
Application #
2165317
Study Section
Special Emphasis Panel (ZRG1-VISA (01))
Project Start
1996-07-01
Project End
1997-06-30
Budget Start
1996-07-01
Budget End
1997-06-30
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Centaur Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Sunnyvale
State
CA
Country
United States
Zip Code
94085
Comments
Be the first to comment on Kenneth Narducy's grant